Kearns P J, Coleman S, Wehner J H
Division of Clinical Nutrition, Santa Clara Valley Medical Center, San Jose, California 95128, USA.
JPEN J Parenter Enteral Nutr. 1996 Jan-Feb;20(1):20-4. doi: 10.1177/014860719602000120.
This two-part study initially evaluated complications associated with catheters inserted via upper extremity veins. The second prospective phase compared thrombotic risk of peripheral catheter tips vs a central vein terminus.
Patients from public institutions with infectious diseases were observed throughout their inpatient and outpatient use of IV catheters. Seventy-two and 39 patients enrolled in phase 1 and phase 2, respectively. Phase 1 consisted of prospective observations and analysis of complications and associated risk factors. Phase 2 randomized patients to a catheter tip location in the superior vena cava or the axillosubclavian-innominate vein and compared the incidence of thrombosis, phlebitis, and infection.
In phase 1, there was an increased risk of thrombosis with peripheral tip localization (61% vs 16%, p < .05). Phase 2 confirmed increased thrombosis with tips in the axillosubclavian-innominate vein compared with the superior vena cava (60% vs 21%, p < .05) with an improved survival for central tip catheters (p < .02). Catheters associated with thrombosis were more likely to become infected (r = 0.48, p < .02).
The experience supports use of the long arm catheter as an effective device for parenteral therapy. A novel method for placing these catheters makes most patients candidates for this approach. Placing a long arm-catheter's tip in the central venous circulation reduces the risk of thrombosis. A high incidence of tip misdirection indicates a need for radiographic confirmation before use.
这项分为两部分的研究最初评估了经上肢静脉插入导管相关的并发症。第二个前瞻性阶段比较了外周导管尖端与中心静脉末端的血栓形成风险。
对来自公共传染病机构的患者在住院和门诊使用静脉导管期间进行观察。分别有72名和39名患者参与了第一阶段和第二阶段。第一阶段包括对并发症及相关危险因素的前瞻性观察和分析。第二阶段将患者随机分为导管尖端置于上腔静脉或腋锁骨下无名静脉两组,比较血栓形成、静脉炎和感染的发生率。
在第一阶段,外周尖端定位的血栓形成风险增加(61%对16%,p<.05)。第二阶段证实,与上腔静脉相比,腋锁骨下无名静脉尖端的血栓形成增加(60%对21%,p<.05),中心尖端导管的生存率有所提高(p<.02)。与血栓形成相关的导管更易发生感染(r = 0.48,p<.02)。
该经验支持使用长臂导管作为肠外治疗的有效装置。一种放置这些导管的新方法使大多数患者适合采用这种方法。将长臂导管尖端置于中心静脉循环可降低血栓形成风险。尖端误置的发生率较高表明在使用前需要进行影像学确认。